aTyr Pharma Inc.

NASDAQ: ATYR · Real-Time Price · USD
4.90
-0.09 (-1.80%)
At close: Aug 15, 2025, 3:59 PM
4.93
0.60%
After-hours: Aug 15, 2025, 06:43 PM EDT

aTyr Pharma Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a 235K n/a 353K n/a n/a 10.39M n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
387K 383K 175K 388K 383K 770K 407K 993K 586K 755K 697K 414K 286K 298K 320K 329K n/a n/a
Gross Profit
-387K -383K -175K -388K -383K 235K -407K -640K -586K -755K 9.69M -414K -286K -298K -320K -329K n/a n/a
Operating Income
-20.31M -15.77M -15.82M -18.14M -17.32M -16.64M -15.96M -12.62M -13.56M -12.79M -7.95M -13.49M -12.58M -12.38M -8.64M -7.73M -10.45M -7.2M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-19.53M -14.88M -14.97M -17.26M -16.31M -15.49M -14.76M -11.34M -12.34M -11.95M -7.52M -13.24M -12.42M -12.15M -8.56M -7.67M -10.39M -7.16M
Net Income
-19.53M -14.88M -14.97M -17.26M -16.31M -15.49M -14.76M -11.34M -12.34M -11.95M -7.52M -13.24M -12.42M -12.15M -8.56M -7.67M -10.39M -7.15M
Selling & General & Admin
4.93M 3.96M 3.59M 3.34M 3.34M 3.51M 2.8M 1.66M 3.13M 2.65M 2.73M 3.21M 3.16M 3.18M 2.37M 2.26M 2.79M 2.69M
Research & Development
15.38M 11.81M 12.23M 14.81M 13.97M 13.36M 12.76M 10.32M 9.84M 9.38M 14.91M 9.87M 9.13M 8.9M 5.96M 5.14M 7.66M 4.52M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
20.31M 15.77M 15.82M 18.14M 17.32M 16.87M 15.55M 11.97M 12.97M 12.03M 17.64M 13.08M 12.3M 12.08M 8.32M 7.4M 10.45M 7.2M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a -407K -993K -586K -755K -697K -414K n/a n/a n/a n/a n/a n/a
Cost & Expenses
20.31M 15.77M 15.82M 18.14M 17.32M 16.87M 15.96M 12.97M 13.56M 12.79M 18.34M 13.49M 12.58M 12.38M 8.64M 7.73M 10.45M 7.2M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -2K -2K n/a n/a
Shares Outstanding (Basic)
90.12M 86.49M 82.72M 75.8M 72.28M 66.08M 59.26M 57.89M 55.14M 41.9M 29.12M 28.66M 28.06M 27.82M 27.79M 18.16M 16.13M 14.1M
Shares Outstanding (Diluted)
90.12M 86.49M 82.72M 75.8M 72.28M 66.08M 59.26M 57.89M 55.14M 41.9M 29.12M 28.66M 28.06M 27.82M 27.79M 18.16M 16.13M 14.1M
EPS (Basic)
-0.22 -0.17 -0.18 -0.23 -0.23 -0.23 -0.25 -0.2 -0.22 -0.29 -0.26 -0.46 -0.44 -0.44 -0.31 -0.42 -0.64 -0.51
EPS (Diluted)
-0.22 -0.17 -0.18 -0.23 -0.23 -0.23 -0.25 -0.2 -0.22 -0.29 -0.26 -0.46 -0.44 -0.44 -0.31 -0.42 -0.64 -0.51
EBITDA
-20.31M -15.39M -15.82M -17.75M -16.93M -15.87M -15.55M -11.62M -12.97M -12.03M -7.25M -13.08M -12.3M -12.08M -8.32M -7.4M -10.09M -6.91M
EBIT
-19.53M -15.77M -15.82M -18.14M -17.32M -16.64M -15.96M -12.62M -13.56M -12.79M -7.95M -13.49M -12.58M -12.38M -8.64M -7.73M -10.45M -7.2M
Depreciation & Amortization
387K 383K -1K 388K 383K 770K 407K 993K 586K 755K 697K 414K 286K 298K 320K 329K 358K 297K